ÂÜÀòÂÒÂ×

Carlos Chang has a long and varied work experience. Carlos began their career in 2004 as a Graduate Researcher in Biomedical Engineering at the University of Arizona, where they also served as Webmaster for the Biomedical Engineering Department. In 2007, they were a Visiting Scientist at NASA, where they developed and optimized an experiment for shuttle mission STS-118 and took on multiple support and leadership roles for the Cell Culture Module - A (CCM-A) research team. In the same year, they were a Postdoctoral Fellow at the Cardiovascular Innovation Institute, where they utilized adipose derived cells and isolated microvessel fragments to develop biomedical devices and regenerative therapies. From 2012 to 2014, they were Assistant Program Manager at Saint Joseph's Translational Research Institute (SJTRI), where they were Study Director (GLP studies) and Principal Investigator (non-GLP studies). From 2014 to 2017, they were a Senior Product Development Engineer at CorMatrix Cardiovascular, Inc., where they led product development efforts, evaluated medical device designs, and developed models to investigate a wide range of biologically derived materials. Since 2020, they have been Technical Director of R&D and Manufacturing and Senior Product Development Engineer at Avery Therapeutics, Inc.

Carlos Chang has obtained four degrees in total. Carlos first obtained a BS in Materials Science and Engineering from Alfred University. Carlos then received a BFA in 2D and Electronic Studies from Alfred University. After that, they earned a PhD in Biomedical Engineering from the University of Arizona. Lastly, they obtained a Doctor of Philosophy - PhD in Biomedical Engineering from the University of Arizona.